Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
40.8M
-
Shares change
-
+3.5M
-
Total reported value, excl. options
-
$678M
-
Value change
-
+$66.6M
-
Put/Call ratio
-
0.65
-
Number of buys
-
91
-
Number of sells
-
-41
-
Price
-
$16.64
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2016
167 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2016.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
of 58.9M outstanding shares and own 69.23% of the company stock.
Largest 10 shareholders include Palo Alto Investors, LLC (4.11M shares), DEERFIELD MANAGEMENT CO (3.44M shares), GREAT POINT PARTNERS LLC (2.71M shares), PAULSON & CO. INC. (2.18M shares), MORGAN STANLEY (1.84M shares), MILLENNIUM MANAGEMENT LLC (1.68M shares), VANGUARD GROUP INC (1.67M shares), BlackRock Fund Advisors (1.59M shares), STATE STREET CORP (1.38M shares), and MACQUARIE GROUP LTD (1.29M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.